Endo International plc DPO Ratio 2011-2026 | ENDP

Annual DPO Ratio Endo International plc

2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
39.3	38.8	32.5	24.8	23.6	21.5	14	17.6	60.5	80.4	92.4	121	89.2

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
121	14	50.4

Quarterly DPO Ratio Endo International plc

2023-Q3	2023-Q2	2023-Q1	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
35.4	36	40.3	-	30.7	33.1	37.4	-	34.3	29.9	29.7	-	24.8	25.6	23	-	23.8	23.9	23	-	21.2	22.9	20.5	-	15.1	14.4	14.5	-	51.1	44.9	43.1	-	74.2	72.2	76.2	-	79.6	89.5	118	-	93.2	87.9	47.2	-	-	-	-	-	-	-	-

All numbers in USD currency

Indicator range from quarterly reporting

Maximum	Minimum	Average
118	14.4	43.5

DPO Ratio of other stocks in the Drug manufacturers industry

Issuer	DPO Ratio	Price	% 24h	Market Cap	Country
AcelRx Pharmaceuticals ACRX	38	-	7.5 %	$ 6.35 M	USA
Agile Therapeutics AGRX	352	-	10.11 %	$ 58.2 M	USA
Assertio Holdings ASRT	122	$ 18.41	-1.02 %	$ 118 M	USA
Adamis Pharmaceuticals Corporation ADMP	345	-	0.86 %	$ 117 M	USA
Aerie Pharmaceuticals AERI	116	-	-	$ 754 M	USA
Catalent CTLT	41.8	-	-	$ 11.5 B	USA
DURECT Corporation DRRX	519	-	-	$ 50.1 M	USA
Evoke Pharma EVOK	5.36 K	-	-	$ 36.6 M	USA
Alimera Sciences ALIM	309	-	-	$ 142 M	USA
Athenex ATNX	111	-	-23.39 %	$ 1.76 M	USA
Avadel Pharmaceuticals plc AVDL	224	-	-	$ 2.06 B	France
Harrow Health HROW	199	$ 36.73	3.67 %	$ 1.35 B	USA
Cumberland Pharmaceuticals CPIX	775	$ 3.14	2.28 %	$ 44.1 M	USA
Cronos Group CRON	212	$ 2.53	0.4 %	$ 1.33 B	Canada
Jupiter Wellness JUPW	318	-	-	$ 33.6 M	USA
Lannett Company LCI	36.8	-	1.15 %	$ 7.11 M	USA
Bausch Health Companies BHC	78.1	$ 5.35	1.71 %	$ 1.95 B	Canada
Aurora Cannabis ACB	-807	$ 3.43	1.78 %	$ 86.3 M	Canada
Canopy Growth Corporation CGC	52.8	$ 1.04	4.83 %	$ 112 M	Canada
Organogenesis Holdings ORGO	94	$ 2.39	5.75 %	$ 315 M	USA
Pacira BioSciences PCRX	37.3	$ 23.25	3.2 %	$ 1.08 B	USA
PetIQ PETQ	54.2	-	1.64 %	$ 400 M	USA
ProPhase Labs PRPH	45.4	-	-	$ 5.07 M	USA
Eagle Pharmaceuticals EGRX	75.6	-	-39.89 %	$ 27.7 M	USA
Evolus EOLS	59.4	$ 4.09	0.25 %	$ 264 M	USA
Emergent BioSolutions EBS	55.8	$ 8.39	6.88 %	$ 430 M	USA
Radius Health RDUS	274	-	-	$ 1.42 B	USA
Recro Pharma REPH	6.63	-	-4.76 %	$ 65.3 M	USA
SCYNEXIS SCYX	20.2	$ 1.0	3.87 %	$ 49.9 M	USA
OptiNose OPTN	194	-	-	$ 1.08 B	USA
Sonoma Pharmaceuticals SNOA	32.3	$ 2.29	3.62 %	$ 2.84 M	USA
Tilray TLRY	53	$ 6.75	4.49 %	$ 4.17 B	Canada
Veru VERU	264	$ 2.55	2.82 %	$ 344 M	USA
Viatris VTRS	64	$ 13.57	3.12 %	$ 16.3 B	USA
cbdMD YCBD	84	$ 0.7	-0.19 %	$ 3.02 M	USA
Zomedica Corp. ZOM	64.3	-	-0.21 %	$ 98 M	USA
Rockwell Medical RMTI	15.4	$ 0.94	-1.12 %	$ 33.8 M	USA
China Pharma Holdings CPHI	47.6	$ 0.62	1.57 %	$ 2.66 M	China
TherapeuticsMD TXMD	723	$ 2.05	1.49 %	$ 23.7 M	USA